Neko Health, a company known for its cutting-edge AI technology, has raised $700 million in a Series C funding round led by Lightspeed Venture Partners and co-led by O.G. Venture Partners. This investment will help expand the company's preventive screening service, which combines medical imaging, blood tests, proprietary sensors, and clinician review.
The new funding comes as Neko Health looks to further grow its presence in the US market, with plans to open a clinic in New York. The company aims to leverage its technology to improve health outcomes by providing more accurate and accessible screening services for individuals of all ages.
Neko Health's technology has been gaining attention in recent years due to its potential to revolutionize healthcare by using AI to analyze vast amounts of data and identify patterns that may not be visible to human clinicians. The company's innovative approach is already being adopted by several major health organizations, including the Centers for Disease Control and Prevention (CDC).